The Drugs Controller General of India (DCGI) on Friday gave its permission to Bharat Biotech for conducting trials of intranasal booster doses against the coronavirus disease (Covid-19).
According to an input from news agency ANI, the trials will be held at nice different sites.
India will start administering the precautionary third doses of Covid vaccines from Jan 10. It will be given to health workers, frontline workers & senior citizens with co-morbidities. The decision to administer this 3rd dose was taken in view of the recent global surge of Covid cases. It was announced by PM Modi last month amid demands of boosters in…
A day ago, the Hyderabad-based pharmaceutical company’s anti-Covid vaccine Covaxin was recently granted regular market approval for use in the adult population subject to certain conditions. A similar nod has also been given to Serum Institute of India’s Covishield. Both the widely used vaccines in the country’s fight against the pandemic had so far been grante restricted use in emergency situations.
You may also like
-
India’s Genome Is Not Western: GenomeIndia Study Calls for India-Specific Precision Medicine
-
CDSCO Tightens Drug Safety Reporting Rules, Asks Firms to File PSURs From Actual Launch Date
-
Cumin in Ayurveda — The Ancient Digestive Spice That Became a Daily Medicine in Indian Kitchens
-
ICMR Transfers Three Indigenous Medical Technologies to Industry at National Technology Day 2026
-
AIIMS Delhi Introduces India’s First Portable Bedside MRI System for Critical Brain Imaging
